Cargando…
Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) cells lack the expression of ER, PR and HER2. Thus, TNBC patients cannot benefit from hormone receptor-targeted therapy as non-TNBC patients, but can only receive chemotherapy as the systemic treatment and have a worse overall outcome. More effective therapeutic...
Autores principales: | Yu, Yong, Qi, Jingjing, Xiong, Jieyi, Jiang, Liping, Cui, Di, He, Junlin, Chen, Ping, Li, Lianjie, Wu, Chenjie, Ma, Tonghui, Shao, Su, Wang, Jianjun, Yu, Dansong, Zhou, Bing, Huang, Dongsheng, Schmitt, Clemens A., Tao, Ran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376470/ https://www.ncbi.nlm.nih.gov/pubmed/30809307 http://dx.doi.org/10.7150/thno.29520 |
Ejemplares similares
-
Gene enhancer deregulation and epigenetic vulnerability
por: Lu, Rui, et al.
Publicado: (2016) -
Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders
por: Muto, Tomoya, et al.
Publicado: (2013) -
Analysis of TET2 and EZH2 gene functions in chromosome instability in acute myeloid leukemia
por: Wang, Jingyi, et al.
Publicado: (2020) -
MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL
por: Poole, Candace J., et al.
Publicado: (2019) -
SMYD2 aggravates gastrointestinal stromal tumor via upregulation of EZH2 and downregulation of TET1
por: Ji, Yong, et al.
Publicado: (2022)